Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67260775

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
BerandaProdukAPI dan perantaraBubuk apisDabrafenib Mesylate Powder CAS No.1195768-06-9

Dabrafenib Mesylate Powder CAS No.1195768-06-9

  • $1
    ≥1
    Gram
Jenis pembayaran:
L/C,T/T,Paypal,Others
Inkoterm:
FOB,CFR,CIF,CPT
Min. Memesan:
1 Gram
Transportasi:
Ocean,Air,Express,Others
Pelabuhan:
Shanghai ,Guangzhou ,Shenzhen
Share:
  • Deskripsi Produk
Overview
Atribut Produk

Model NoDM 1195768-06-9

Purity99.0%+

AppearanceOff-white to white powder

Kemampuan Pasokan & Informasi Tambahan

KemasanPE ganda dengan tas foil

ProduktivitasStock Available

TransportasiOcean,Air,Express,Others

Tempat asalHebei, Cina

SertifikatISO9001

PelabuhanShanghai ,Guangzhou ,Shenzhen

Jenis pembayaranL/C,T/T,Paypal,Others

InkotermFOB,CFR,CIF,CPT

& pengiriman paket
Menjual unit:
Gram
Tipe paket:
PE ganda dengan tas foil

PRODUCT DETAILS

Name: Dabrafenib Mesylate

CAS NO.1195768-06-9 

Other Name:Dabrafenib Mesylate (GSK-2118436);Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API)
Appearance:Off-white to white powder

Kemurnian: 99,0 %+


Paket & Pengiriman

Paket: Tas PE Ganda dengan tas foil atau sesuai

waktu pengiriman yang diperlukan: Stok Tersedia

Port: Port apa pun di China

Kategori Produk : API dan perantara > Bubuk apis

Email ke pemasok ini
  • *Subjek:
  • *Untuk:
    Ms. Lily
  • *Email:
  • *Pesan:
    Pesan Anda harus antara 20-8000 karakter
BerandaProdukAPI dan perantaraBubuk apisDabrafenib Mesylate Powder CAS No.1195768-06-9
Kirim permintaan
*
*

Rumah

Product

Phone

Tentang kami

Permintaan

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Kirim